Navigation Links
Tumors use enzyme to recruit regulatory T-cells and suppress immune response
Date:8/16/2007

IDO appears to be a sort of linchpin; its a crossroads where a number of mechanisms, some of which are more powerful than IDO itself, come together, says Dr. Munn. Tregs, for example, are much more powerful than IDO. If you take a mouse and remove IDO, it compensates just fine. If you remove Tregs, the mouse dies. But if the tumor uses IDO to recruit and activate Tregs, that is a leverage point.

Therapies aimed at these new leverage points will be most effective when packaged with other emerging and existing treatments, he says.

The FDA has approved early clinical trials of the IDO inhibitor, 1MT, in coming months. A team, led by longtime collaborator Dr. Scott Antonia, hematologist/oncologist and co-leader of the Immunology Program at the H. Lee Moffitt Cancer Center and Research Institute, will begin phase 1 trials of 1MT in patients with lung and other tumors shortly. MCG is pursuing FDA approval to begin trials of the combination of 1MT and chemotherapy in breast cancer patients. Dr. Munn notes that while the IDO inhibitor seems to be a safe drug that doesnt cause autoimmune disorders in mice, it wont be used in patients with autoimmune disorders because it could worsen the disorders.

By combining IDO with chemotherapy, researchers hope to wipe the slate clean of the tumors manipulation of the immune response, says Dr. Munn. We have found that once the tumor gets a hold of the immune system, just giving an IDO inhibitor does not restore everything to normal. The tumor has too much influence on the immune system at that point.

Standard doses of chemotherapy reduce immune system function, creating a window where IDO likely can be more effective. That window may work for cancer vaccines too, which are still under study and getting mixed reviews. Recent reports indicate vaccines can actually increase the number of Tregs in mice with tumors, a problem when fighting cancer but a possible opportunity in which an IDO inhibitor m
'/>"/>

Contact: Toni Baker
tbaker@mcg.edu
706-721-4421
Medical College of Georgia
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Use of Cellular Phones associated with Increased risk of Brain Tumors
2. Radiofrequency Energy Cooks Tumors Without Surgery
3. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
4. Finasteride lowers risk of prostate cancer but increases risk of high-grade tumors
5. New Technique For Benign Breast Tumors
6. Morphine may excite cancerous tumors
7. Benign eye tumors being treated
8. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
9. Same molecule found in meat, milk, tumors
10. Another Treatment Option for Benign Tumors
11. Understanding The Origin Of Tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Springs, LA (PRWEB) September 01, 2014 ... Intervention Instructor training, Derek is currently pursuing counselor certification ... able to advance through the CPI training program as ... states "and I have grown both personally and professionally. ... permanently recover, I am competently able to do so. ...
(Date:9/1/2014)... The National Association of Hispanic Nurses ( ... DNP, MPH, RN, and Adriana Perez, PhD, Rn, ANP-BC, ... Nursing. They will be inducted with Immediate Past President ... we reported last May. , Our three members will ... American Academy of Nursing Policy Conference in Washington, DC. ...
(Date:9/1/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... AND GLOBAL MARKETS , the global market for blood-brain ... is expected to reach $38.7 million in 2014. This ... 2019, which is equivalent to 64.9% compound annual growth ... (RMT) segment is forecasted to grow at a CAGR ...
(Date:9/1/2014)... York (PRWEB) September 01, 2014 ... retrieve, organize and analyze biological and genetic data. ... the activity of developing software tools to generate ... to be confused with biological computation. While bioinformatics ... understanding of biology can its related concepts, biological ...
(Date:9/1/2014)... In honor of National Take Your Cat to the Vet Day, ... of Minnesota (AERC) is offering a few reasons why pet owners ... people don’t take their cat to the vet because “there’s nothing ... decide not to take their kid to dentist because he or ... pets. Just like people want their loved ones to be healthy, ...
Breaking Medicine News(10 mins):Health News:Narconon Louisiana Announces New Certifications For Staff 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 2Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 3Health News:Two Additional NAHN Members to be Inducted as Fellows of the American Academy of Nursing 4Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 2Health News:Bioinformatics Market: A fusion of Computers and Biological Data 3Health News:Bioinformatics Market: A fusion of Computers and Biological Data 4Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 2Health News:Animal Emergency & Referral Center of Minnesota Celebrates National Take Your Cat to the Vet Day 3
... LAKE FOREST, Ill., July 29 Akorn, Inc. (Nasdaq: AKRX ) will ... will host a conference call on Tuesday, August 11 to discuss quarterly results followed by ... Akorn Second ... Tuesday, August 11, 2009 at 10:00 a.m. Eastern Time, ...
... July 29 Sanofi-aventis U.S. announced today that the ... poly-L-lactic acid) for the correction of shallow to deep ... wrinkles which are treated with the appropriate injection technique ... natural-looking results that can last up to two years. ...
... FRANKLIN PARK, Ill., July 29 JEWEL-OSCO, ... Tinley Park-based Physicians Prompt Care Centers ... care option designed to meet the needs of busy southwestern ... Care Express physicians will offer high-quality, convenient and affordable ...
... prevention efforts, researcher says, , WEDNESDAY, July 29 (HealthDay ... a role in disrupting the memory formation process long ... of Alzheimer,s disease, a new study contends. , Previous ... damage neurons and are characteristic of Alzheimer,s disease, begin ...
... BLOOMFIELD HILLS, Mich., July 29 Great Expressions Dental ... a dental practice in Canton, MI that was established in 1977, ... Dr. Jack Falvo, owner of Willow Creek Dental Care, stated: "The ... personalized approach to dental care. Now as part of Great ...
... ... Provides Reliable Network, Service and Coverage , ... Houston, TX (PRWEB) July 29, 2009 -- KelseyCare Advantage ... Fort Bend, Montgomery, and Galveston on the Mainland, announced the enrollment of their 10,000th ...
Cached Medicine News:Health News:Akorn, Inc. Announces Second Quarter 2009 Earnings Release and Conference Call Information 2Health News:FDA Approves Sculptra(R)Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles 2Health News:FDA Approves Sculptra(R)Aesthetic, a Facial Injectable for Correction of Nasolabial Folds and Other Facial Wrinkles 3Health News:Physicians Prompt Care Health Clinic Opens in Orland Park JEWEL-OSCO(R) 2Health News:Physicians Prompt Care Health Clinic Opens in Orland Park JEWEL-OSCO(R) 3Health News:Protein Clumps May Appear Years Before Memory Problems 2Health News:Great Expressions Dental Centers, Inc. Acquires Willow Creek Dental Care in Canton, MI 2Health News:KelseyCare Advantage Enrolls 10,000th Member 2Health News:KelseyCare Advantage Enrolls 10,000th Member 3
(Date:9/1/2014)... , Sept. 1, 2014 Research ... " Early-Stage Minimally-Invasive Biomarkers in Alzheimer,s Disease: A ... Opportunities, 2014" report to their offering. ... study of new developments relating to early-stage minimally-invasive biomarkers ... existing AD drugs and candidates in the AD drug ...
(Date:8/30/2014)... Aug. 30, 2014  Boston Scientific has released ... TherApy foR Heart Failure (NECTAR-HF) clinical trial, the ... vagus nerve stimulation (VNS) for the treatment of ... of Therapeutics and Cardiology and Director of the ... la Sante et de la Recherche Medicale presented ...
(Date:8/30/2014)... Mass. , Aug. 30, 2014   Royal ... of Affiniti, a new ultrasound system designed ... the demands of increasing patient volumes and cost pressures. ... Congress 2014 in Barcelona ... departments facing more patients with fewer resources deliver high ...
Breaking Medicine Technology:Early-Stage Minimally-Invasive Biomarkers in Alzheimer's Disease: A Comprehensive Analysis and Market Study of New Developments and Opportunities, 2014 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4
... 2012  Ventana Medical Systems, Inc. (Ventana), a member ... has entered into a strategic collaboration agreement with ... companion diagnostic test intended to identify patients most ... conjugate (ADC). Ventana,s diagnostic immunohistochemistry platform aims to ...
... CareFusion today announced its Alaris System wireless ... to receive a new data encryption certification now required ... Affairs hospital networks. (Logo: http://photos.prnewswire.com/prnh/20100706/CAREFUSIONLOGO ) ... Standard (FIPS) 140-2, certifies that the Alaris System ...
Cached Medicine Technology:Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 2Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy 3CareFusion Receives Federal Data Encryption Certification for Alaris® Infusion System 2
First to USA-market, this revolutionary technology combines CBC and CRP analysis for stat results of 17 parameters within 4.5 minutes!...
StarClose Clip Applier, (includes), Clip Applier, 6F Exchange Sheath, 6F Dilator, 0.038 50 cm J-Tip Guide Wire ...
... Delivering 3.5x, 4.5x and 5.5x magnification., ... Prismatic quality guarantees a true image. ... color rendition is ideal for intricate ... are treated with an anti-reflective coating ...
... and 3.0x magnification. The true benefit of ... while maintaining focal clarity is made possible ... The lightweight aluminum bar and individual pupillary ... and optimal focal alignment, eliminating headache and ...
Medicine Products: